Becton, Dickinson and Company (BDX)의 가격은 얼마입니까?

Becton, Dickinson and Company (BDX)의 가격은 $183.43입니다.

Becton, Dickinson and Company (BDX)의 시가 총액은 무엇입니까?

Becton, Dickinson and Company (BDX)의 시가 총액은 $50.54B입니다.

Becton, Dickinson and Company (BDX) 발행주식수

Operating globally, Becton, Dickinson and Company (BD) is a prominent enterprise focused on the development, manufacturing, and distribution of a broad spectrum of medical technology. This includes essential medical supplies, sophisticated devices, advanced laboratory equipment, and critical diagnostic products. Its extensive customer base comprises healthcare providers, clinical institutions, medical researchers, pharmaceutical firms, and the general public around the world. The BD Medical division delivers a comprehensive suite of products primarily focused on medication management and drug delivery. This encompasses a variety of intravenous (IV) access solutions, such as peripheral and advanced catheters, central lines, acute dialysis catheters, and related vascular care items including needle-free connectors and closed-system drug transfer devices. It also provides essential injection equipment like hypodermic syringes, needles, anesthesia trays, enteral syringes, and sharps disposal systems. Additionally, this segment develops integrated systems for IV medication and infusion therapy, medication compounding workflow, automated dispensing, and supply chain optimization. Specialized products for diabetes management, including pen needles, along with prefillable drug delivery systems, are also key offerings. BD Life Sciences focuses on diagnostic and research tools, offering products for specimen and blood collection. This segment supplies automated systems for culturing blood and tuberculosis, molecular testing, microorganism identification, and drug susceptibility analysis. It also provides liquid-based cytology systems, rapid diagnostic assays, microbiology laboratory automation, and plated media. Furthermore, it offers advanced solutions for cell analysis, including fluorescence-activated cell sorters and analyzers, antibodies, kits, and reagent systems. These are crucial for single-cell gene expression analysis, as well as for clinical oncology, immunological, and transplantation diagnostics and monitoring. Finally, the BD Interventional segment delivers specialized products for surgical and interventional procedures. Its portfolio includes solutions for hernia and soft tissue repair, biological and bioresorbable grafts, and biosurgery, alongside other surgical products. This segment also addresses surgical infection prevention, provides a range of surgical and laparoscopic instrumentation, offers peripheral intervention products, and supplies urology and critical care devices. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.

연도	발행 주식 수	변화
2026 (TTM)	274.79M	-4.13%
2025	286.61M	-1.09%
2024	289.76M	1.22%
2023	286.28M	0.45%
2022	285.01M	-1.48%
2021	289.29M	3.70%
2020	278.97M	3.34%
2019	269.94M	4.49%
2018	258.35M	18.00%
2017	218.94M	2.93%
2016	212.70M	5.02%
2015	202.54M	4.78%
2014	193.30M	-0.95%
2013	195.16M	-5.01%
2012	205.46M	-7.11%
2011	221.18M	-5.61%
2010	234.33M	-2.56%
2009	240.48M	-1.57%
2008	244.32M	-0.35%
2007	245.19M	-0.92%
2006	247.46M	-1.62%
2005	251.53M	0.01%
2004	251.51M	-1.19%
2003	254.54M	-1.37%
2002	258.07M	0.27%
2001	257.37M	1.64%
2000	253.23M	0.00%

연도

발행 주식 수

변화

2026 (TTM)

274.79M

-4.13%

2025

286.61M

-1.09%

2024

289.76M

1.22%

2023

286.28M

0.45%

2022

285.01M

-1.48%

2021

289.29M

3.70%

2020

278.97M

3.34%

2019

269.94M

4.49%

2018

258.35M

18.00%

2017

218.94M

2.93%

2016

212.70M

5.02%

2015

202.54M

4.78%

2014

193.30M

-0.95%

2013

195.16M

-5.01%

2012

205.46M

-7.11%

2011

221.18M

-5.61%

2010

234.33M

-2.56%

2009

240.48M

-1.57%

2008

244.32M

-0.35%

2007

245.19M

-0.92%

2006

247.46M

-1.62%

2005

251.53M

0.01%

2004

251.51M

-1.19%

2003

254.54M

-1.37%

2002

258.07M

0.27%

2001

257.37M

1.64%

2000

253.23M

0.00%

회사	발행 주식 수	차이	국가
Intuitive Surgical, Inc. ISRG.US	354.50M	29.01%	US
EssilorLuxottica S.A. EL.PA	461.20M	67.84%	FR
HOYA Corporation 7741.T	-	-	JP
Alcon Inc. ALC.SW	-	-	CH
Medline Inc. MDLN.US	-	-	US

회사

발행 주식 수

차이

국가